Human immunodeficiency virus nef signature sequences are associated with pulmonary hypertension

AIDS Research and Human Retroviruses

Volumn 28, Issue 6, 2012, Pages 607-618

  Almodovar, Sharilyn ^a,b   Knight, Rob ^c   Allshouse, Amanda A ^a   Roemer, Sarah ^b   Lozupone, Catherine ^c   McDonald, Daniel ^c   Widmann, Jeremy ^c   Voelkel, Norbert F ^d   Shelton, Robert J ^b   Suarez, Edu B ^e   Hammer, Kenneth W ^b   Goujard, Cecile ^f   Petrosillo, Nicola ^g   Simonneau, Gerald ^h   Hsue, Priscilla Y ⁱ   Humbert, Marc ^h   Flores, Sonia C ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e University of Puerto Rico at Ponce   (Puerto Rico)

^f INSERM   (France)

^g NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN;

ADULT; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE DURATION; DOWN REGULATION; EUROPE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG PARENCHYMA; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PULMONARY HYPERTENSION; TISSUE SECTION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANIMALS; COHORT STUDIES; DISEASE MODELS, ANIMAL; FEMALE; HIV-1; HUMANS; HYPERTENSION, PULMONARY; MACACA MULATTA; MALE; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PHYLOGENY; SAN FRANCISCO; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 84861855413     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0021     Document Type: Article

References (43)

1. Tuder RM, Groves B, Badesch DB, and Voelkel NF: Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275-285.
2. Speich R, Jenni R, Opravil M, Pfab M, and Russi EW: Primary pulmonary hypertension in HIV infection. Chest 1991;100(5):1268-1271.
3. Petrosillo N, Chinello P, and Cicalini S: Pulmonary hypertension in individuals with HIV infection. AIDS 2006;20(16): 2128-2129.
4. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al.: Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Criti Care Med 2008;177:108-113.
5. Ntsekhe M and Hakim J: Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation 2005;112(23):3602-3607.
6. Thenappan T, Shah SJ, Rich S, and Gomberg-Maitland M: A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30(6):1103-1110.
7. Hsue PY, Deeks SG, Farah HH, et al.: Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 2008;22(7):825-833.
8. Nunes H, Humbert M, Sitbon O, et al.: Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2003;167(10):1433-1439.
9. Clarke JR, Krishnan V, Bennett J, Mitchell D, and Jeffries DJ: Detection of HIV-1 in human lung macrophages using the polymerase chain reaction. AIDS 1990;4(11): 1133-1136.
10. Twigg III HL, Weiden M, Valentine F, et al.: Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. J Infect Dis 2008;197(1): 109-116.
11. Barber SA, Gama L, Li M, et al.: Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: Compartmentalized regulation of SIV. J Infect Dis 2006;194(7):931-938.
12. Piguet V, Schwartz O, Le GS, and Trono D: The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol Rev 1999;168:51-63.
13. Swann SA, Williams M, Story CM, Bobbitt KR, Fleis R, and Collins KL: HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway. Virology 2001;282(2):267-277.
14. Deacon NJ, Tsykin A, Solomon A, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270(5238): 988-991.
15. Kestler HW, III, Ringler DJ, Mori K, et al.: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65(4):651-662.
16. Kirchhoff F, Easterbrook PJ, Douglas N, et al.: Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol 1999;73(7): 5497-5508.
17. Marecki JC, Cool CD, Parr JE, et al.: HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nefinfected macaques. Am J Respir Crit Care Med 2006;174(4): 437-445.
18. Mandell CP, Reyes RA, Cho K, et al.: SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques. Virology 1999;265(2):235-251.
19. Humbert M, Sitbon O, Chaouat A, et al.: Pulmonary arterial hypertension in France: Results from a national registry. Am J Respir Crit Care Med 2006;173(9):1023-1030.
20. Drummond AJ, Ashton B, Cheung M, et al.: Geneious v5.0. http://www.geneious.com.
21. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22(22):4673-4680.
22. Kelley LA and Sternberg MJ: Protein structure prediction on the Web: A case study using the Phyre server. Nat Protoc 2009;4(3):363-371.
23. Delano WL: The PyMol molecular graphics system: Delano scientific, 2002.
24. Lovell SC, Davis IW, Arendall WB, III, et al.: Structure validation by Calpha geometry: Phi,psi and Cbeta deviation. Proteins 2003;50(3):437-450.
25. Chesebro B and Wehrly K: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988;62(10):3779- 3788.
26. Lozupone CA, Hamady M, Cantarel BL, et al.: The convergence of carbohydrate active gene repertoires in human gut microbes. Proc Natl Acad Sci USA 2008;105(39):15076-15081.
27. Saksela K, Cheng G, and Baltimore D: Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef + viruses but not for down-regulation of CD4. EMBO J 1995;14(3):484-491.
28. Grzesiek S, Stahl SJ, Wingfield PT, and Bax A: The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 1996;35(32):10256-10261.
29. Piguet V, Wan L, Borel C, et al.: HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat Cell Biol 2000;2(3): 163-167.
30. Shugars DC, Smith MS, Glueck DH, Nantermet PV, Seillier- Moiseiwitsch F, and Swanstrom R: Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol 1993;67(8):4639-4650.
31. Roeth JF, Williams M, Kasper MR, Filzen TM, and Collins KL: HIV-1 Nef disrupts MHC-I trafficking by recruiting AP- 1 to the MHC-I cytoplasmic tail. J Cell Biol 2004;167(5): 903-913.
32. Salgado M, Brennan TP, ÓConnell KA, et al.: Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors. Retrovirology 2010;7:94.
33. Fu W, Sanders-Beer BE, Katz KS, Maglott DR, Pruitt KD, and Ptak RG: Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res 2009;37(Database issue):D417-D422.
34. George MP, Brower A, Kling H, et al.: Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques. AIDS Res Human Retroviruses 2011;27(2):103-111.
35. Foster J and Garcia JV: HIV-1 Nef: At the crossroads. Retrovirology 2008;5:84.
36. Laguette N, Bregnard C, Benichou S, and Basmaciogullari S: Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Molec Asp Med 2010;31(5):418-433.
37. Arhel NJ and Kirchhoff F: Implications of Nef: Host cell interactions in viral persistence and progression to AIDS. Curr Topics Microbiol Immunol 2009;339:147-175.
38. Geyer M, Fackler OT, and Peterlin BM: Structure-function relationships in HIV-1 Nef. EMBO Rep 2001;2(7):580-585.
39. Mwimanzi P, Hasan Z, Hassan R, Suzu S, Takiguchi M, and Ueno T: Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef́s functionality in primary macrophages. Retrovirology 2011;8:50.
40. Acs P, Beheshti M, Szallasi Z, Li L, Yuspa SH, and Blumberg PM: Effect of a tyrosine 155 to phenylalanine mutation of protein kinase cdelta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts. Carcinogenesis 2000;21(5): 887-891.
41. Jung J, Byeon IJ, Ahn J, and Gronenborn AM: Structure, dynamics, and Hck interaction of full-length HIV-1 Nef. Proteins 2011;79(5):1609-1622.
42. Dong T, Zhang Y, Xu KY, et al.: Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. Blood 2011;118(1):98-106.
43. Culmann B, Gomard E, Kieny MP, et al.: An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immunol 1989;19(12): 2383-2386.